Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
1781-1803
Author(s):
Rawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, Nathalie Okdeh, Hervé Pietra, Rabih Roufayel, Christian Legros, Ziad Fajloun* and Jean-Marc Sabatier*
Drugs to Treat Neuroinflammation in Neurodegenerative Disorders
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
1818-1829
Author(s):
Yao-Chin Wang, Woon-Man Kung, Yi-Hsiu Chung* and Sunil Kumar*
An Update on the Role of Circadian Rhythms in Sleep Disorders
Journal:
Current Drug Therapy
Volume:
19
Page:
302-316
Author(s):
Namra Aziz, Vipin Kumar Garg, Yadav Rupali Vinod, Arpit Gupta, Ankita Wal, Shruti Rathore and Pranay Wal*
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
1608-1619
Author(s):
Marco Zeppieri* and Mutali Musa
Role of Omega-3PUFA: A Nutraceutical for Brain Functioning and Treatment of Mental Disorders
Journal:
Current Indian Science
Volume:
1
Page:
1-15
Author(s):
Ishu Garg, Raj Kumari* and Meenakshi Sharma
Neurobiological Staging with Special Reference to Sleep Apnoea Syndrome: An Update
Journal:
Current Indian Science
Volume:
1
Page:
1-8
Author(s):
Anuj Kumar Sharma and Mayank Kulshreshtha*
Infectious Mononucleosis: An Updated Review
Journal:
Current Pediatric Reviews
Volume:
20
Page:
305-322
Author(s):
Alexander K.C. Leung*, Joseph M. Lam and Benjamin Barankin
Potential Benefits of Psilocybin for Lupus Pain: A Case Report
Journal:
Current Rheumatology Reviews
Volume:
20
Page:
97-99
Author(s):
Sofia Audrey B. Gonzales, Christine Alexopoulos and Daniel G. Arkfeld*
Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
2921-2939
Author(s):
Ranjit K. Harwansh*, Paras Yadav and Rohitas Deshmukh
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
2752-2762
Author(s):
Israa M. Shamkh*, Mahmoud Elkazzaz, Enas. S. Radwan, Jawayria Najeeb, Md. Tabish Rehman, Mohamed F. AlAjmi, Moayad Shahwan, Muhammad Sufyan, Nouf Khalifa Alaqeel, Ibrahim A. Ibrahim, Basit Jabbar, Mohammad Shahbaz Khan, Tomasz M. Karpiński, Abdullah Haikal*, Reem M. Aljowaie, Saeedah Musaed Almutairi and Amr Ahmed